poliomyelitis
Showing 1 - 25 of 160
Poliomyelitis Trial in Dhaka (Novel oral poliomyelitis vaccine type 1 (nOPV1), Novel oral poliomyelitis vaccine type 2 (nOPV2),
Not yet recruiting
- Poliomyelitis
- Novel oral poliomyelitis vaccine type 1 (nOPV1)
- +3 more
-
Dhaka, BangladeshInternational Centre for Diarrhoeal Disease Research
Nov 14, 2023
Poliomyelitis Trial in Geelong, Melbourne (Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) (VLP-Polio), Inactivated
Not yet recruiting
- Poliomyelitis
- Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) (VLP-Polio)
- +3 more
-
Geelong, Victoria, Australia
- +1 more
Oct 30, 2023
Neurologic Disorder, Parkinson Disease, Spinal Cord Injuries Trial in Fort Smith (HIFT)
Not yet recruiting
- Neurologic Disorder
- +7 more
- HIFT
-
Fort Smith, ArkansasArkansas Colleges of Health Education
Jul 18, 2023
Diphtheria, Tetanus, Pertussis Trial (DTaP-HepB-IPV-Hib vaccine)
Not yet recruiting
- Diphtheria
- +5 more
- DTaP-HepB-IPV-Hib vaccine
- (no location specified)
Jul 11, 2023
Poliomyelitis, Polio Trial in Dhaka, Gujranwala, Karachi (Sabin Strain Inactivated Poliovirus Vaccine)
Not yet recruiting
- Poliomyelitis
- Polio
- Sabin Strain Inactivated Poliovirus Vaccine
-
Dhaka, Bangladesh
- +2 more
Apr 28, 2023
Poliomyelitis Trial (nOPV2)
Not yet recruiting
- Poliomyelitis
- nOPV2
- (no location specified)
Dec 22, 2022
Poliomyelitis Trial in Dhaka (SII Inactivated Salk Polio Vaccine (Adsorbed) - Lot A, SII Inactivated Salk Polio Vaccine
Recruiting
- Poliomyelitis
- SII Inactivated Salk Polio Vaccine (Adsorbed) - Lot A
- +3 more
-
Dhaka, BangladeshInternational Centre for Diarrhoeal Disease Research, Bangladesh
Dec 24, 2022
Poliomyelitis Trial in Panama City (Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3), Sabin Monovalent Oral
Not yet recruiting
- Poliomyelitis
- Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3)
- Sabin Monovalent Oral Poliomyelitis Vaccine Type 3 (mOPV3)
-
Panama City, Panama
- +3 more
Dec 14, 2022
Poliomyelitis Trial in Dhaka (Novel Live Attenuated Type 1 Oral Poliomyelitis Vaccine (nOPV1), Sabin Monovalent Oral
Not yet recruiting
- Poliomyelitis
- Novel Live Attenuated Type 1 Oral Poliomyelitis Vaccine (nOPV1)
- Sabin Monovalent Oral Poliomyelitis Vaccine Type 1 (mOPV1)
-
Dhaka, BangladeshInternational Centre for Diarrhoeal Disease Research, Bangladesh
Nov 30, 2022
Poliomyelitis Trial (Intradermal fractional dose inactivated polio vaccine (fIPV) in combination with recombinant double mutant
Recruiting
- Poliomyelitis
- Intradermal fractional dose inactivated polio vaccine (fIPV) in combination with recombinant double mutant heat labile toxin, LT(R192G/L211A), (dmLT)
- +2 more
-
Burlington, VermontUniversity of Vermont Vaccine Testing Center at the Larner Colle
Sep 2, 2022
Poliomyelitis Trial in United States (Novel Oral Polio Vaccine Type 1 (nOPV1), Novel Oral Polio Vaccine Type 3 (nOPV3), Sabin
Active, not recruiting
- Poliomyelitis
- Novel Oral Polio Vaccine Type 1 (nOPV1)
- +3 more
-
Baltimore, Maryland
- +3 more
Aug 24, 2022
Poliomyelitis Trial in Dhaka (Full dose Sabin Inactivated Poliovirus Vaccine produced by IMBCAMS, Fractional (1/5) Dose Sabin
Not yet recruiting
- Poliomyelitis
- Full dose Sabin Inactivated Poliovirus Vaccine produced by IMBCAMS
- +3 more
-
Dhaka, BangladeshIcddr,B Study Clinics
Jul 13, 2022
Diphtheria, Tetanus, Pertussis Trial (LBVD (Hexavalent vaccine), Pentavalent vaccine and Inactivated Polio vaccine (Sabin
Not yet recruiting
- Diphtheria
- +5 more
- LBVD (Hexavalent vaccine)
- Pentavalent vaccine and Inactivated Polio vaccine (Sabin strains)
- (no location specified)
Jul 13, 2022
Poliomyelitis, Vaccine Reaction Trial (Eupolio)
Not yet recruiting
- Poliomyelitis
- Vaccine Reaction
- Eupolio
- (no location specified)
Jun 23, 2022
Poliomyelitis Trial in Gao'an, Pingxiang (sIPV vaccine /DTaP vaccine, sIPV vaccine /Hepatitis A inactivated vaccine /MMR
Recruiting
- Poliomyelitis
- sIPV vaccine /DTaP vaccine
- sIPV vaccine /Hepatitis A inactivated vaccine /MMR vaccine
-
Gao'an, Jiangxi, China
- +1 more
Jun 20, 2022
Poliomyelitis Trial in Kaifeng, Xuchang (Experimental vaccine, IPV control vaccine, single-person sIPV control vaccine)
Active, not recruiting
- Poliomyelitis
- Experimental vaccine
- +2 more
-
Kaifeng, Henan, China
- +1 more
May 24, 2022
Poliomyelitis Trial in Dhaka (fIPV (0.1 mL) ID, fIPV (0.1mL) IM, fIPV (0.2mL) IM)
Terminated
- Poliomyelitis
- fIPV (0.1 mL) ID
- +3 more
-
Dhaka, Bangladeshicddr,b study clinics (Mirpur and CTU Dhaka)
May 11, 2022
Physical Activity in People With Sequelae of Poliomyelitis
Recruiting
- Poliomyelitis
- standard of care for patients with poliomyelitis sequelae
-
Garches, FranceDepartment of Physical Medicine and Rehabilitation, Raymond Poin
May 3, 2022
Sabin Inactivated Poliovirus Vaccine(Vero Cell) After Four Doses
Recruiting
- Poliomyelitis
- Investigational sIPV
- Control IPV
-
Pizhou, Jiangsu, ChinaPizhou county Center for Disease Control and Prevention
Apr 12, 2022
Diphtheria, Tetanus, Pertussis Trial in Thai Binh (Hexaxim®)
Completed
- Diphtheria
- +5 more
- Hexaxim®
-
Thai Binh, VietnamPreventive Medicine Centre of Thai Binh Province
Mar 24, 2022
Diphtheria, Tetanus, Pertussis Trial in Seoul (TETRAXIM™: Combined adsorbed diphtheria, tetanus, acellular pertussis and
Completed
- Diphtheria
- +3 more
- TETRAXIM™: Combined adsorbed diphtheria, tetanus, acellular pertussis and enhanced inactivated polio
-
Seoul, Korea, Republic of(unnamed)
Mar 15, 2022
Poliomyelitis Trial in David, Panamá (nOPV2 (monovalent oral polio vaccine))
Completed
- Poliomyelitis
- nOPV2 (monovalent oral polio vaccine)
-
David, Chiriquí, Panama
- +1 more
Jan 20, 2022
Immunity Duration Against Polio Over 18 Months Infants After 2
Completed
- Poliomyelitis
- Sabin strain inactivated polio vaccine
-
Jinan, ChinaShandong Center for Disease Control and Prevention
Mar 7, 2022
Poliomyelitis Trial (bOPV and nOPV2)
Withdrawn
- Poliomyelitis
- bOPV and nOPV2
- (no location specified)
Dec 29, 2021
Poliomyelitis Trial in Wilrijk, Ghent (Novel OPV2 candidate 1, Novel OPV2 candidate 2, Placebo)
Completed
- Poliomyelitis
- Novel OPV2 candidate 1
- +2 more
-
Wilrijk, Antwerp, Belgium
- +1 more
Sep 18, 2021